ArticleFrontiers in oncology2026
Symptom networks in breast cancer patients during chemotherapy and their impact on daily living status.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Insomnia in Breast Cancer: A Neglected Symptom Cluster.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Few current studies explore the relationships among chemotherapy - related symptoms in breast cancer patients from different perspectives, and the link between symptoms and daily life is unclear. Objective: To construct a symptom network for breast cancer patients during chemotherapy and explore symptom - symptom relationships from multiple perspectives. Methods: The Anderson Symptom Inventory was used to collect symptom data and daily - life interference of 480 patients. R software built the symptom network, and edge - weight and centrality difference tests identified core symptom clusters. Results: The 480 female patients had a mean age of 52.46 years. Symptoms were common during chemotherapy, like fatigue and restless sleep. Fatigue was the core symptom in the overall network, but it varied among groups with different chemotherapy cycles and BMI. Distress had the greatest impact on daily life. Conclusion: Attention should be paid to psychological and emotional symptoms, and priority symptoms for intervention should be selected based on the symptom network. Future research should develop dynamic symptom networks and centrality index trajectories using longitudinal data. Implications for practice: Nurses can implement precise symptom management based on the symptom network. Meanwhile, comprehensive assessments of patients' psychological and emotional problems should be initiated from the early stage of chemotherapy, and symptom management methods should be selected according to the severity of patients' conditions to improve their psychological and emotional well - being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.